University of California San Francisco
Give to UCSFBabies who undergo fetal surgery — pioneered at UCSF 30 years ago — to repair spina bifida while still in the womb develop better than babies who have corrective surgery after birth, according to findings from a UCSF-led trial.
A new study led by Kristine Jaffe at the San Francisco VA Medical Center and UCSF, finds different results with estrogen therapy and dementia, depending on when a woman takes the hormone.
Five basic scientists at UCSF will be awarded the distinction of fellows by the American Association for the Advancement of Science (AAAS) on February 19.
UCSF researchers have developed a new approach to decoding the vast information embedded in an organism’s genome, while shedding light on exactly how cells interpret their genetic material to create RNA messages and launch new processes in the cell.
UCSF researchers have tackled a decade-long scientific conundrum, and their discovery is expected to lead to significant advances in using stem cells to treat genetic diseases before birth.
Low blood levels of beta-amyloid 42, a protein-like substance, were associated with the risk of significant cognitive decline within nine years in a group of elders, in a study led by Kristine Yaffe, MD, chief of geriatric psychiatry at the San Francisco VA Medical Center.
The bodies of virtually all U.S. pregnant women carry multiple chemicals, including some banned since the 1970s and others used in common products such as non-stick cookware, processed foods and personal care products, according to a new study from UCSF.
Sanofi-Aventis and UCSF have formed two research and development collaborations that join together leaders from academia and industry to more rapidly advance groundbreaking innovation from the lab to the patient.
Susan Hyde, an award-winning professor and scientist with the UCSF School of Dentistry, promotes practices that preserve oral health and quality of life for both patients and practitioners.
Parkinson’s disease researcher Robert Nussbaum, a human geneticist and neuroscientist at UCSF, has been named to receive the prestigious Klaus Joachim Zülch Neuroscience Prize for 2011.
In a recent UCSF-led study in mice, researchers developed a method to stabilize living lung tissue for imaging without disrupting the normal function of the organ. The method allowed the team to observe, for the first time, both the live interaction of living cells in the context of their environment and the unfolding of events in the immune response to lung injury.
Weight gain and environmental pollutants might be linked, an award-winning worm researcher suggests.
A small-scale University of California, San Francisco-led study has identified the first evidence in humans that exposure to bisphenol A (BPA) may compromise the quality of a woman’s eggs retrieved for in vitro fertilization (IVF).
Brain cancers are deadly more often than not, but UCSF researchers have determined that a particular genetic signature in is associated with longer survival, a discovery that may lead to better therapies for some of the deadliest brain cancers.
For patients with glioma, the most common primary brain tumor, new findings may explain why current therapies fail to eradicate the cancer. A UCSF-led team of scientists has identified for the first time that progenitor rather than neural stem cells underly a type of glioma called oligodendroglioma.
A team of UCSF researchers has engineered E. coli with the key molecular circuitry that will enable genetic engineers to program cells to communicate and perform computations.
Ophir Klein wants to use stem cells to grow teeth. Because teeth are simple in comparison to large, vital organs, they may serve as a proving ground for regenerative medicine.
UCSF Nobel laureate Stanley Prusiner, MD, and colleagues have called for Congress to more than quadruple annual federal funding for Alzheimer’s research, saying that with a dedicated effort, there is a chance for a breakthrough against the disease by 2020.
<p>Scientists this week are moving into the headquarters for the Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research at UCSF, where they will continue to advance a field transformed by the revolutionary achievement of Shinya Yamanaka.</p>
New technologies and techniques continue to accelerate the pace of discovery in human genetics research, a fact made clear by scientists who spoke about their searches for important mutations, gene variants and answers to basic biological questions at the UCSF Institute for Human Genetics’ fifth-anniversary symposium on Oct. 28.
Half of teens who have oral sex during the ninth grade will have intercourse by the end of the 11th grade, and most sexually active teenagers will begin engaging in oral sex and sexual intercourse within the same six-month period, according to findings from a new survey conducted by researchers at UCSF and UC Merced.
<em>The Lancet</em> launched a special series on malaria elimination Oct. 29, led by the Global Health Group (GHG), a part of UCSF Global Health Sciences. The series included work by 36 authors worldwide, with guidance and support provided by a GHG-convened global advisory group of malaria experts, known as the Malaria Elimination Group.
UCSF scientists have received two grants from the California Institute for Regenerative Medicine to refine their human embryonic stem cell-based strategies for treating neurological diseases and liver failure.
UCSF Nobel laureate Stanley B. Prusiner, professor of neurology and director of the Institute for Neurodegenerative Diseases, today (Oct. 15, 2010) was named to receive the National Medal of Science, the nation’s highest honor for science and technology.
On Tuesday, October 19, 2010, San Francisco VA Medical Center bone researcher and former NCIRE Board of Directors member Robert A. Nissenson, PhD, will receive the 2010 Shirley Hohl Service Award from the American Society for Bone and Mineral Research (ASBMR).
A diet supplemented with powdered dried plum restored bone lost by mice during the course of normal aging, in a study led by Bernard P. Halloran, PhD, at the San Francisco VA Medical Center.